Effects of Omega-3 in the treatment of violent schizophrenia patients
Schizophrenia Research Aug 24, 2017
Qiao Y, et al. Â The aim of the present study was to explore the relationship in between the daily consumption of fish oil (360 mg DHA + 540 mg EPA), and reduction of symptoms and violent behavior among patients with schizophrenia. According to the findings obtained, violent schizophrenia patients treated with fish oil (360 mg DHA + 540 mg EPA) showed a reduction in violence, but improvement in positive and negative symptoms was no greater than patients treated with the placebo after 12 weeks.
Methods
- In a twelve week, double-blind supplementation trial, 50 inpatients meeting ICD-10 criteria for schizophrenia and scoring more than four of Modified Overt Aggression Scale (MOAS) with antipsychotics treatment were randomly assigned to receive either fish oil (N = 28) or a placebo (N = 22).
- After that, assessments were performed at baseline and at weeks 4, 8 and 12
Results
- The results of this study showed that the PANSS and CGI scores diminished at the week of 4, 8 and 12, however, no differences were found between the 2 groups.
- Findings revealed that MOAS scores declined significantly at weeks 4, 8 and 12.
- In addition, MOAS scores of the fish oil group declined significantly than the placebo group (t = -2.40, P < 0.05) at week 12.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries